Related Experiment Video
Updated: Sep 30, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Early clinical trial of antineoplastic agents--recent perspectives of pharmacological analysis in phase I study]
1Division of Oncology and Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
Abstract:
Importance pharmacological analysis has been widely recognized in conducting early clinical trials of antineoplastic agents, especially phase I trials, in recent years. Pharmacokinetic-pharmacodynamic analysis during dose escalation process is one of the extremely important research endpoints in phase I trials. In addition, measurement of protein unbound drug concentration is more informative for understanding pharmacological difference between patients and animals. Achievable plasma drug concentration which would be compared with preclinical results might be useful surrogate marker to decide optimum administration dose for further clinical investigation in conducting phase I trials of non-cytotoxic or molecular targeting drugs.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Discovery: Overview
Clinical Trials: Overview
Preclinical Development: Overview
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

